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Abstract 
Background: ​This project was prompted by the ambition to investigate, from the outset, the              
potential consequences of a future translation to a human context of research on natural death               
prediction today actively conducted in the biology of ageing field. It is centered on ethical issues,                
challenges faced in medical decision processes and finally their implications in economic and             
insurance matters. Recent advances in biology have made predicting the onset of natural death a               
technically feasible prospect. 
Methods: ​This project resulted in a study ahead of application based on an interdisciplinary              
approach, a combination of philosophy, clinical psychology, medicine, demography, biology and           
actuarial science. The question was put into perspective with regard to contemporary theories of              
ageing as well as our understanding of what death is. Philosophy (literature review and conceptual               
analysis) and psychology (theory and clinical experience) have allowed us to break down into distinct               
themes the individual relationship to death, its anticipation and its prediction in order to better               
understand the challenges that the prediction of natural incoming death might raise. Our approach              
to the problem in the medical field has been focused on intensive care because of the high                 
frequency of death secondary to acute illnesses. It is therefore natural that we have examined how                
the development of tools to predict the risk of death could become a medical decision-making tool                
and enable the teams involved to better cope with it. Demographic and actuarial approaches have               
allowed us to put prediction of death in the context of the long-standing analysis of mortality tables.                 
Novel methods of death prediction pose new challenges to long-established assumptions of            
 
demographic models used in the implementation of pension and public health policies and insurance              
decisions. 
Outcomes: This interdisciplinary work has led to the co-construction of a framework for scientific and               
ethical reflection that can be relevant to define public health policy. Unlike a downstream approach               
that only provides data after the fact or at least after society has adopted a scientific and/or                 
technological innovation, this work strives to accompany the implementation of the innovation and             
to anticipate its effects. 
Interpretation: In this study, we propose a first sketch of what the implications of death prediction as                 
such could be - inasmuch as it affects both the awareness of death and its anticipation - ​from an                   
individual, medical and social point of view​. The potential benefits of such tools for society may yet                 
be outweighed by ethically problematic applications. Here, we seek to provide a framework for              
reflection ahead of such applications.  
Funding:​This project was partially funded by the IHSS (Institut Humanités, Sciences et Sociétés,             
Université Paris Diderot), the CNRS (Centre National de la Recherche Scientifique) and ATIP/Avenir             
young group leader program.  
 
Introduction  
Death prediction is not a new idea, neither at a population level nor at an individual one. Since                  
the late 17th century, demographers have routinely estimated and analysed multiple           
population-level death-related parameters commonly summarised in life-tables. For instance, the          
Human Mortality Database now gathers and      
distributes high-quality data for 40 countries      
(online access : ​http://www.mortality.org/​;    
consulted August 6th 2019). At the other end        
of the spectrum, medical teams from fields       
such as nephrology, intensive care and      
oncology take into account median life      
expectancy in everyday prognosis and design      
of treatment strategy, without necessarily     
discussing this parameter with patients.  
In the past few years, the discovery of        
biomarkers of ageing has led to the       
development of predictors of impending     
natural death and has paved the way for        
personalised estimation of the risk of death       
in the general population. Recently     
published research has focused on the      
prediction of high risks of mortality in       
apparently healthy adults, echoing the first      
description in 2011 of the Smurf phenotype,       
a harbinger of natural death in ​Drosophila       
melanogaster​. These recent findings suggest     
that the end-of-life is 1) molecularly and       
physiologically highly stereotyped, 2)    
evolutionarily conserved and 3) predictable. 
Taken together, these results from     
independent groups studying multiple    
 
organisms including humans and using different approaches, delineate future directions in ageing            
research. The ability to identify and characterise individuals about to die of natural causes is a                
game-changer in this field. It also brings to the forefront the notion that death is no longer seen as                   
an event, a final point on a given timeline; rather, it is considered as a process with variations from                   
one species to the other as well as amongst individuals.  
There is little doubt that the discovery of predictors of impending natural death in apparently               
healthy adults will have major ethical implications for both individuals and society. Such new              
knowledge will inevitably bring changes to one’s personal attitude toward one’s death. The potential              
public health and economic uses of this research should be investigated with equal attention. 
The purpose of this study is, first of all, to briefly portray the historical evolution of biological                 
thinking about death​, ​the ongoing research on predictors of impending natural death, and the              
prospects it holds within the biology of ageing. We will then examine the ethical resources available                
to approach the idea of death as a process, to consider the perspective of death prediction and to                  
formulate their implications. In particular, we will examine the scope of philosophical and             
psychological analysis of what it means for a person “to be mortal” and to anticipate one’s own                 
death. This examination will allow us to highlight the specificity and novelty of the issues raised by                 
the research on predictors of impending natural death, both from an individual and a social point of                 
view. Finally we will outline issues that call for further investigation in the various fields concerned:                
ethical, psychological, medical and social.  
Natural death as a predictable process 
A broad range of age-related patterns of mortality are observed across species, from negligible              
senescence to post-reproductive death through progressive age-dependent risk increase​1​. The          
present discussion mostly builds upon work conducted in ​Drosophila melanogaster and in humans.             
In both species increasing mortality is observed with age (the definition of “ageing” we adopt), which                
leads to sigmoidal survival curves or type I survivorship curves​2​. In humans, the increase in mortality                
with age has been acknowledged at least since the first life-table was computed by John Graunt in                 
1662​3​; the exponential nature of the force of mortality for most of adult life has been put forward as                   
early as 1825​4​. 
 
 
 
Figure 1: Different types of survivorship      
curves​. Humans, most mammals and     
model organisms such as ​Drosophila     
melanogaster ​and ​Caenorhabditis elegans    
have Type I survivorship curves with death       
primarily occurring in old age. Birds and       
some reptiles have a Type II survivorship       
curve, whereas trees and marine     
invertebrates have a Type II curve. 
Image credit: Population demography: Figure 5 by 
OpenStax College, Biology, CC BY 4.0 
 
 
Early conceptions of ageing and     
death. ​Despite these long-recognised    
statistical regularities, the nature of     
ageing was long ignored by biologists.      
For decades, ageing and death were      
mostly seen as natural phenomena –      
 
so natural indeed that they did not warrant an explanation. Though the idea of death as a natural                  
phenomenon was explicitly formulated by Linné, early attempts to explain death can be found in               
Paracelse, and later Metchnikoff, who both interpreted death as a chronic poisoning of the organism               
– an idea further developed by subsequent theories such as the Oxidative Stress Theory of Ageing​2​. 
The second half of the 19​th ​century represents a turning point in the understanding of ageing. Two                 
decades after Darwin’s ​On the origin of species​5 ​was published, German evolutionary biologist             
August Weisman published his own theory of ageing in mammals​3​. Its key idea was that the                
limitation of lifespan occurred for evolutionary reasons: since death allows the replacement and the              
transformation of generations, it fosters progress and evolution. The idea that ageing is a trait               
selected by evolution, and as such ​programmed, ​was therefore introduced. 
  
Evolutionary vs. functionalist biology on death. ​The 20​th ​century staged the confrontation between             
two biologies – the first one seeking to answer the ​why ​(evolutionary biology); the second one the                 
how ​(functionalist biology). Much greater emphasis was placed on the latter with the discovery of               
DNA, the rapid development of molecular biology tools and, regarding ageing, the discovery of the               
first enzymes detoxifying the Reactive Oxygen Species​6​, echoing Harman’s free radical theory of             
ageing​7​. 
On the one hand, the functionalist conception - which partly took up Weismann's reflections              
- further developed the idea that there is an ​ageing program​, coded and contained in an organism’s                 
genome. Although Weisman justifies its existence invoking evolutionary reasons (at the species            
level), the idea of a "programmed death" as such s​eems to go against darwinian evolution, since fitness                 
crucially depends on survival, and hence on postponement of death. This was the main argument used                
against Weisman’s vision of ageing as being adaptive. The notion of a "program" can for instance be                 
found in François Jacob’s work, e.g. in his book ​the Logic of life​8​ : 
 
"death [is] imposed from within, as a necessity prescribed from the egg onward by the genetic                
programme itself." 
 
From this perspective, death is clearly part of a process that begins, if not at birth, then at least                   
several years before the individual's time of death. 
Evolutionary theories, on the other hand, long denied the possibility of ageing and death being               
deliberately programmed by the organism. They expounded on the fundamental role of chance and,              
in this sense, seem to be more in line with Darwinian theories.  
Recent evolutionary theories of ageing. ​From the 1950s onwards, three major evolutionary theories             
were introduced. According to Medawar’s theory of accumulation of mutations, published in 1952,             
ageing is caused by the progressive accumulation of deleterious mutations with effects that manifest              
only late in life. Because selective pressure decreases with age (fertility being considerably higher at               
younger ages), such mutations are not systematically eliminated by natural selection and can be              
considered responsible for the development of genetic traits leading to old age and death. Williams’               
antagonistic pleiotropy ​theory goes a little further than Medawar’s, by inferring the existence of              
genes and mutations with antagonistic effects: beneficial at an early age (and therefore selected by               
evolution), they would also explain negative manifestations of aging and eventually lead to death.              
Finally, the so-called ​“disposable soma” theory as formulated by statistician Thomas Kirkwood, was             
based on the idea that the individual has a limited amount of energy, shared between reproductive                
functions and (non-reproductive) maintenance functions of the organism, the “soma”. According to            
Kirkwood’s theory, the increase in mammalian longevity is linked to a decrease in growth and               
reproduction rates, delaying death. 
In each case, ageing was interpreted as a continuous process resulting from 1) the accumulation of                
deleterious mutations, 2) the expression of antagonist genes, or 3) the use of a limited amount of                 
disposable energy – leading to an individual’s death. 
 
Current functionalist approaches. ​These evolutionary theories coexisted until functionalist         
approaches became dominant in the 1980s. Evolutionary conserved mechanisms of ageing were            
discovered in model organisms such as ​C. elegans ​and ​D. melanogaster ​(oxidising agents, nutrients              
sensing deficiencies, protein aggregation, telomere attrition, cellular senescence, inflammation,         
etc.)​9 with the first longevity-promoting genetic mutation identified in nematodes by Cynthia Kenyon             
and collaborators in 1993​10​, later shown to be conserved in flies​11​, mice​12​ and humans​13​.  
Nowadays, numerous theories still coexist. Attempts have been made at classifying them into broad              
categories, such as: “evolutionary theories” vs. “mechanistic theories”; “programmed theories” vs.           
“damage/error theories”; “cellular” vs. “physiological” vs. “organ-based” vs. “genetic theories”.          
However, a more prevalent approach today is to try and link together the mechanisms and               
phenomena that are already well-known and explained. Some new theories were proposed as an              
attempt to build a unified version of ageing​14,15​.  
  
Predictors of death. ​Whether death is ​programmed ​– genetically – or not, it may still be ​predicted​.                 
The most readily accessible predictor of the mortality risk, and perhaps the most widely studied, is                
chronological age, or, to put it plainly, the amount of time an individual has been alive. As previously                  
mentioned, life-tables based on the mortality experience of whole populations have revealed that, in              
humans, the risk of death increases exponentially with chronological age for most of adult life. It                
should be noted that this approach yields an incomplete perspective of the ageing process at an                
individual level, since the interpretability of a life-table is to some extent based on the assumption of                 
a homogeneous population. In cases where individuals experience different levels of risk, e.g. due to               
genetic or developmental characteristics, the population-level mortality trajectory depends on the           
age-related increase in mortality, but also on the distribution of the aforementioned            
characteristics​16​. Accordingly, chronological age alone fails to identify impending death situations,           
except at extreme ages. It has recently been estimated in Italian centenarians that the force of                
mortality reached a plateau at 0.645 y​- after age 105​17​. In other words, approximately 50% (1-e​-0.645​)                
of individuals who have reached this age are expected to die within one year.  
This line of reasoning leads to the notion of physiological age: two individuals of the same                
chronological age can experience different risks of impending death. 
  
Death prediction based on processes. ​One crucial question that we have so far largely set aside is                 
that the notion of death may refer either only to a ​single ​moment, or to a process. Indeed, d​eath is                    
most often represented as an event ​- a point on the arrow of time, e.g. in classical survival analysis                   
methods commonly used in epidemiological or demographic research. ​The idea that stands in             
contrast to this first one is that of death as a ​process ​including a risk phase that precedes the final                    
event​, ​as first delineated by Buffon in his ​Histoire naturelle de l’homme​18​. 
The latter perspective on death has been given renewed impetus by the recent identification in               
drosophila flies of an increase in intestinal permeability (the “Smurf phenotype”) that systematically             
occurs during aging and precedes impending death​19,20​. While Smurf individuals have a markedly             
decreased life expectancy, compared to non-Smurf individuals, no - or little - effect of chronological               
age on death rates was found among Smurfs individuals. Flies randomly transition to the Smurf               
state, then die. Since the first description of the Smurf phenotype, ​in vivo ​assessment of intestinal                
barrier dysfunction associated with ageing has been performed in other model organisms​21 (figure             
2). The interesting point to highlight here is the scaling of Smurf-phase duration depending on the                
life expectancy of the considered organism. From 2-4 days in nematodes and drosophila - in which                
we first described this ​impending death phenotype - characterized by a 20-90 days lifespan, the               
Smurf phase duration goes up to approximately 6 months in the zebrafish ​Danio rerio, which has a                 
5-year life expectancy. It is now reasonable to posit that increased intestinal permeability is linked to                
evolutionary conserved mechanisms and could potentially be observed in humans, although this            
“Smurf period” might last years​22​. Results recently published by Angarita and collaborators​23 further             
bolster this hypothesis (figure 3).  
 
This characterisation of death as a process has major implications for prediction, since observation of               
whether a fly has reached the Smurf state - its physiological age - predicts its risk of impending death                   
better than its chronological age does. ​In humans, recent work has actually built upon the               
assumption that death is a process in the course of which progression to intermediate states can be                 
observed and therefore yield insights into survival even for​ apparently healthy individuals​.  
 
Figure 2: Evolutionary conservation of the Smurf phenotype through 900 million years of evolution.              
(published in​21​) 
 
Accumulating evidence points to the notion that predictions based on specific biomarkers can             
significantly outperform predictions based on risk factors and chronological age. Horne and            
coauthors for instance showed that a risk-score based on complete blood count and metabolic              
information led to accurate prediction of survival in the short (at 30 days) to medium term (at 5                  
years) in the general population​24​.  
In 2014, Fisher et al. performed biomarker profiling by nuclear magnetic resonance in two large               
groups of people​25​. They combined test results of four selected biomarkers (plasma albumin,             
alpha-1-acid glycoprotein, very-low-density-lipoprotein particle size and citrate) into a biomarker          
score that predicted all-cause mortality more accurately than any previously identified risk factors of              
that kind. Other research groups have associated specific age-related mal- or dys-functions to an              
increased risk of all-cause mortality: for example, Pinto et al. have demonstrated that olfactory              
dysfunction is a strong predictor of 5-year mortality in older adults​26​. This heterogeneity amongst              
populations is presently modeled using frailty models ​and various instruments to measure biological             
susceptibility have also been elaborated in order to predict patient outcomes and identify individuals              
with a high-risk of short-term death​27–29​. Others have also focused on specific model organisms to try                
and elucidate significant mechanisms that are associated with ageing and short-term death​20,30–32​. 
This rapidly improving ability to identify at-risk individuals, and therefore to predict with high              
accuracy the occurrence of death for apparently healthy individuals, evidently raises major ethical             
questions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Smurf drosophila and in septic human beings​. (​left​) picture of age-matched ​Drosophila melanogaster               
males that underwent the Smurf assay. In non-Smurf individuals, the blue dye is restricted to the digestive                 
tract while in smurf individuals - showing a high risk of impending death - the blue coloration is extended to                    
the whole body. (​right​) Intestinal permeability - to the blue dye #1 used in the drosophila Smurf Assay - in                    
septic (or not) humans, 2 and 8 hours after dye administration as reported in ​23​. 
Being mortal  
The key question raised by this prospect is to determine whether tools to grasp the implications                
of death prediction for human beings actually exist. We have deliberately limited the examination of               
these issues to human beings - which does not mean that such questioning could not be extended to                  
other living beings. ​We will propose a multilevel analysis by first examining human awareness about               
death and then turning to ​philosophy and psychology, the human condition being a core subject of                
both​. 
  
Philosophy and mortality 
Philosophy will be approached as an academic discipline based on a set of texts beginning with                
pre-Socratic fragments up to contemporary works, so as to offer a multi-layered conceptual analysis              
of core issues. Although both elements (i.e. the texts themselves and the conceptual analysis derived               
from them) vary from one cultural area to another, there are enough common features to consider                
philosophy here as a homogeneous and consistent body of questions and theories. 
Human beings are universally described as being mortal, with death being the endpoint of human               
life. However, some religious and spiritual visions have considered death differently (reincarnation,            
soul transmigrations and rebirth into another world). However, in the present paper, we will take               
mortality as a starting point, whatever one may (or may not) believe happens “after life”. In this                 
perspective, philosophy has paid much attention to the meaning of the mortal condition. Death is               
seen as, if not a defining then possibly the most elemental feature of the human condition, as                 
illustrated in the famous syllogism ​“All men are mortal. Socrates is a man. Therefore, Socrates is                
mortal.'' ​Formulating this point may even appear as an odd thing to do, as no one would question                  
this fact​33​.  
It is often said that human beings are the only living beings who are aware of their own mortality.                   
This awareness, however, comes with a correlated lack of knowledge: although everyone knows they              
are mortal, no one knows when or how they will die. This lack of knowledge is most often seen as a                     
 
positive since knowing one’s own date of death has been depicted as a tragic fate​34​. Death foretold                 
appears tolerable only as a third-person experience​35​.  
This awareness can lead to the belief that human life is devoid of meaning. Although there are                 
various attitudes towards one’s own death, including seeing it as a welcome event (​28 p. 95) to the                  
point of committing suicide​36 (‘Characterization of the Will-to-Live’, Supplements to the Second            
Book, p. 439 sq.)​37​, human beings are generally described as facing the harshest imaginable fate: the                
challenge of accepting, during their lifetime, that their death is coming, and with it, the fact that                 
their achievements, commitments or bonds will fall into oblivion, as if they had not existed​38​.  
Linked to this notion of human life as being meaningless, human mortality is seen as a basic impulse                  
for philosophy itself​36 (‘On Death and its relation to the Indestructibility of our Inner Nature’, ​chapter                
XLI, Supplements to the Fourth Book, ​The World as Will and Idea​, volume II, p. 463). As a reflection                   
on death, philosophers have addressed the quest for immortality from a moral point of view ​39,40​.  
Philosophy has mainly proposed an examination of the feelings or experience induced by the              
awareness of one’s future death. It has done so mostly for human beings, even though attention has                 
been paid to animal sensitivity ​41,42​. Twentieth century philosophy has especially focused on one              
feeling defined as ‘anxiety’ ​43​. Such an ‘anxiety’ - or fear of death - has been commented upon since                   
Ancient times, especially in connection with the strategies developed by human beings to escape the               
thought of death (​44​, series IX, Diversion, 168, p. 44).  
When tackling the issue of mortality, philosophers themselves have searched for ways to prevent              
anxiety about death : thanks to a renewed idea of death as “being nothing to us”​45 (124 sq.)​46​, or in                    
connection with religious consolation ​44​(series XXXIV, 505, p. 122), or with a combative attitude              
against such an anxiety about one’s death, death being seen fully as part of human life​47 (I, XIX, p. 72                    
; III, XIII, p. 571 ; I, XIX, p. 64).  
  
Psychology and mortality  
The analysis of psychic life has brought new insights into human awareness of death. Questioning               
the apparent subjective unity defended by most of Western philosophical thinking, the hypothesis of              
the unconscious introduces the idea that the same subject can be acted upon by multiple internal                
forces that do not all obey the same requirements. Psychic life would therefore be a source of                 
conflict between conscious elements - products of logical thought in accordance with the “reality              
principle ”, and more irrational and unconscious elements abiding by the “pleasure principle” ​48 (vol.               
XII). In this perspective, death can therefore, within the same individual, be consciously invested as               
rational knowledge and concurrently entirely negated by fantasies of immortality - Freud having             
highlighted their kinship with the workings of the unconscious mind​48​ (vol. XIV). 
Psychologists working with people suffering from life-threatening conditions commonly find such           
ambivalence in the patients' discourse, sometimes going as far as dissociation​49–51​. Psychoanalyst            
Michel de M'Uzan radically differentiates the powerful movements that agitate the person close to              
death from those specific to mourning​52 associated with a peaceful acceptance of death​53​. What              
characterises this “​work of dying​”* is therefore not a form of detachment supported by a completely                
passive psyche. As a matter of fact, the psyche shows intense activity when approaching death:               
revolt, vital surge, relational appetence and even creativity of thought actually testify to the conflict               
at work in psychic life when facing the reality of death. 
In this perspective, the emphasis is no longer on denying or accepting representations of death, but                 
rather on the imbalance caused by their resurgence within psychic life. The psychodynamic approach              
therefore aims to identify the psychological processes that allow this balance to endure in order to                
achieve a good life, both individually and collectively; with repression being one such process. These               
 
hypotheses have been widely adopted in the fields of human and social sciences, as evidenced by                
many more contemporary authors who go as far as to point out a genuine collective denial of death                  
54​-​55​. ​According to them, this denial gives even more compelling force to the work of repression and,                 
consequently, make its suppression during an actual encounter with death even less acceptable for              
an individual or a community. Events such as wars, epidemics, being diagnosed with a disease or a                 
disability have an immediate effect as they shatter our “​comforting illusions​” ​48​(vol. XXI) undermining              
all the processes that human societies have devised to escape the constraints nature places on each                
individual.  
Philosophy and psychology have examined the meaning of death awareness for human beings,             
highlighting its existential and psychic implications. However, the focus on this awareness does not              
specifically clarify what it means to anticipate one’s own death.  
 
 
 
* “travail de trépas” 
Anticipating incoming death 
Death anticipation is not uncommon today, particularly in health-care institutions, even though            
practical ways of dealing with it, both individually and collectively, are still in the process of being                 
defined. Extraordinary situations occur where one has a precise idea of the moment of one’s death:                
when a person is sentenced to death, or when a person plans to commit suicide for instance.  
More commonly, anticipation of one’s death occurs in “end-of-life” situations, that is to say, during a                
medically diagnosed time of human life - a few hours, days, weeks or even months - in which the                   
person is considered as entering the last moments of life. We have few historical testimonies or                
literary description of such moments (for example, in Rousseau​56​, Part 6, Letter XI). Today, such               
situations are better documented and more numerous. This is partly due to the contemporary social               
organisation of death in most Western countries (​61 p.6). Another part of the explanation lies in                
“modern scientific capability” which has “profoundly altered the course of human life” yet not              
always made it possible to cure people​57​. The development of intensive care since the 1950s is                
paradigmatic of this “alteration”. It has led to a multiplication of cases where the patient is kept alive                  
and conscious long enough to face the perspective of impending death. Cancerology must also be               
taken into account to understand this shift. In common representations, a cancer diagnosis has long               
meant and still often equates to some sort of death sentence ​58 (p. 35). For this reason, health                  
professionals have developed communication strategies, partial truths and step-by-step         
announcement of such diagnoses​59​. It has been observed that patients may both hope for a cure and                 
be convinced that they are about to die​58​. This is still the case, even with the latest advances in                   
cancerology, which can lead, in certain cases, to cancer becoming chronic.  
Since the late 1960s, the discussion surrounding individual wishes regarding one’s own death             
has become widespread and reached the general public. This qualifies the aforementioned notion of              
both a collective and an individual denial of death. This discussion has informed the way individuals                
anticipate their own deaths. It is now frequent for individuals to express end-of-life preferences;              
manifestoes have been published in newspapers; cases have been brought to court; ethical             
committees have provided guidelines for health professional faced with refusals of treatment and             
expressed wishes to die; reforms have been passed to provide a legal framework for these new ways                 
of facing the end of one’s life in a medical setting ​37,60–62​. 
 
As a result, health-care professionals, medical institutions and societies at large have begun to              
face the challenges posed by death-anticipation for patients. This takes the form of a vivid               
discussion, mostly about what medicine fails to do, could do, or should do better. First, the lack of                  
teaching in medical curricula about the frailty of old patients, about the way they might want to live                  
and die, and about mortality in itself is criticised (​61 p.9). The necessity to make up for it in                   
contemporary health-care systems is now emphasised. In addition, the development of palliative            
care in health-care systems over several decades is viewed as a way to provide answers for this                 
issue, though it has also been criticised for conveying questionable conceptions of what constitutes a               
“good death” and a “good way” to face one’s death​63​. For several decades, certain health-care               
institutions have integrated a new way of practising medicine, no longer focused on trying to cure,                
but rather on providing care to dying persons. Finally, palliative care is not the only answer to                 
criticism aimed at current medical education. Death-anticipation gives rise to other types of             
initiatives such as the recent “anticipated discussions”, which give patients the possibility to discuss              
their “end-of-life” with their physicians​64,65​. 
Advance directives and care for people at the end of their lives stand in contrast to a medicine                  
that states, in the face of therapeutic failure, that “there is nothing more to do”. On the contrary, the                   
palliative care movement, and more broadly the philosophy of care, are based on the idea that                
“there is always something to do with a patient” provided that the care process is focused on the                  
person’s needs and wishes regardless of curative possibilities​66​. 
Psychology actually tells us that it is crucial to maintain one's creativity and ability to think and feel                  
emotions in extreme and unpredictable situations. This necessity can be seen in relation to the               
infant's state of ontological precariousness, with the ability to emerge from it depending on the               
quality of the emotional and human environment provided(Vol. 1)​48,67–71​. Previous research and            
authors have shown that the quality of human support and the environment reduces traumatic              
impact and, even more so, post-traumatic distress. Giving space to the patient's wishes thus              
alleviates their feelings of powerlessness and helps them cope with their situation. 
Freudian and post-Freudian research has carefully examined how, for infants, an experience of             
extreme helplessness in response to an original state of distress becomes the starting point of a                
trauma​48,68,69​. Traumatic feeling comes with "a high state of passivity”, i.e a constrained and              
unwanted experience closely related to this original state of distress​72​. As such, only a permanent               
work of anticipation based on a reliable social environment may allow the individuals concerned to               
protect themselves from it​72​. Experiences in clinical psychology in the context of degenerative             
diseases, certain types of cancer or AIDS - in cases where therapeutic impotence had not been                
overcome – show that people may be unable to modify or reduce this vulnerability for a period of                  
time, which inevitably results in a traumatic experience​73,74​.  
Human creativity, which is so important in human life, would then be considered by some               
authors as the key element of the work of ageing​75​. Death appears as a consequence of the                 
impossibility to continue to age: that is, to keep on transforming somatic and psychic processes in                
order to maintain the balance between the various requirements that allow the continuation of              
life​76​. The reliability of human beings stems from their ability to survive in conditions where their                
greatest precariousness is revealed​76​. 
In both this section and the previous one, the relationship to one’s own death is based on the                  
notion of death as an event interrupting life. Death is considered as the final term, just as it is when                    
used in its metaphorical sense​77​. Anticipation of death is not uncommon but, so far, it has been                 
considered when taking place in a medical context where the person in care suffers from a lethal                 
disease or very poor health condition due to old age. However, the research into predictors for                
 
impending natural death implies that death prediction could become relevant to anyone, at any age,               
and not necessarily solely to persons suffering from a condition; death may equally no longer be                
considered as a fixed event, but rather as a process. This notion has been sketched out once before,                  
but not really developed so far (​56, 57 p. 75). As a result, we must now take another step in our                     
reflection and consider the specifics of death prediction as understood within the research on              
predictors of impending natural death.  
Implications of mortality prediction  
If such predictors were to become widely available, anyone could experience entering a phase of               
life set to a “countdown” (which could last several years). This phase could be described as a very                  
different dying process from what is today labelled as “end-of-life”, and from the experience              
described by anthropologist Todd Meyers about “Beverly”, a person with multiple chronic            
conditions, who refers to her own life as one long dying process​78​. In addition, the notion of                 
prediction​ of death may differ from that of ​anticipation ​of death.  
In the context of this possible future, we address some implications of the widespread availability               
of tools of this kind. In this last section of the study, we propose a first sketch of the implications of                     
predicting death as such, which differs from the awareness of death or even of the anticipation of                 
death as approached in the two previous sections. We will pay special attention to the process as                 
experienced by the person informed of such a prediction, its possible uses in medical              
decision-taking, and finally its possible social and economical uses. We thus hope to anticipate the               
potential outcomes of contemporary biological research on ageing and identify directions for further             
investigation in that field. 
Though still largely theoretical, the experience of entering a phase of life set to a “countdown”                
probably has some common features with a situation we are familiar with: namely, the situation               
arising from genetic testing made in pre-symptomatic stages of a disease. Let us recall here the main                 
points of ethical analysis developed in such a situation. It may help us to foresee the implications of                  
death prediction itself. Particularly interesting insights may be derived from the case of             
pre-symptomatic testing for Huntington’s disease. Reflecting on a family history in her book             
Mapping Fate: A Memoir of Family, Risk, and Genetic Research​, Alice Wexler recounts the life of the                 
author’s mother whose health slowly deteriorates because of Huntington’s disease, and the action             
initiated by her sister and her father to discover the gene causing the disease​82​. The use of the word                   
“fate” suggests that, after receiving their test results, the person affected will not see their life as an                  
open future, but as a timespan closing in on itself. 
This finite course of time appears to be the main issue at stake;​79,80 ​a point that echoes Vladimir                  
Jankélévitch’s analysis of death: on the basis of Victor Hugo’s work of fiction, ​The last day of a                  
condemned man​53​, he emphasised that a death sentence leads a person to enter “an unbearable and                
inhuman” time, where one’s time of death is known​54​. Nietzsche’s anthropological perspective -             
according to which it is better for human beings not to know their future - appears as strikingly                  
relevant on this matter​81​. Along the same lines, Jean-Claude Ameisen states that we live in a state of                  
constant forgetfulness of our previous metamorphoses,​, letting the memory of all the ones that              
occurred before sink into oblivion​82​. In other words, we require a certain ignorance of the future in                 
order to be able to live. Having one’s forthcoming death announced completely breaks with this               
dynamic and, as such, any framework for disclosure should take into account the time and support                
needed to recalibrate one’s choice between ignorance and awareness​83–86​. 
 
Ethical discussions on genetic screening, be it for adults (as used to detect risks of breast cancer)                 
or for children (as used to detect risks of cystic fibrosis or neuromuscular diseases) tend to reach                 
similar conclusions​87–93​. As a result, undergoing genetic testing is not an obvious decision to make.               
Interestingly, only a minority of people who do make it actually complete the process​94 ​95​. This                
information alters the individual’s health status yet it does not provide them with any medical               
response or treatment. In so doing it may definitely raise levels of stress and impair possibilities of                 
planning the future. It also raises the question of the status of the individual who tests positive: will                  
they be considered a patient of medicine, especially so if the announcement comes from a medical                
actor? How can this announcement be managed whilst patients are totally asymptomatic and do not               
feel sick or near death? What kind of support can be offered to them and should it be strictly                   
medical? 
These unresolved questions clearly show specific attention should be paid to the ethical             
implications of death prediction. In terms of decision-making, they call for the elaboration of a               
special process, probably unfolded over a long time period, and on several stages.  
Medical applications and related issues  
Being able to precisely predict impending death would inevitably have medical implications. We             
shall give a few examples of those potential implications and discuss ensuing issues. We will focus                
first on the case of an acutely ill patient with a so-called fatal prognosis, then on a healthy subject                   
diagnosed with a fatal disease. Scientific progress over the past century has considerably increased              
our understanding of human physiology, but many aspects of it are still unknown. Death prediction is                
naturally dependent on the progress of research and medical advances, but it is a new parameter in                 
our end-of life appraisal that must be considered through a patient-based approach. 
Acutely ill with fatal prognosis. After traumatic brain injury, cardiac arrest or septic shock, patients               
may suddenly become comatose or suffer multiple organ failure requiring organ support. Treatment             
for such diseases is dispensed in intensive care units (ICU) and can last up to several weeks at a time.                    
Both patients and family are always very affected by an ICU hospitalisation and relatives may often                
want to know the prognosis of the disease. ​It is unlikely that anyone would wish to ​carry on with                   
invasive treatments in the ICU for a patient with a 100% probability of short-term death. For the                 
most severe cases, clinical scores based on multiple exams - clinical, radiological and biological - are                
precise enough to provide guidance as to the withdrawal of treatment, which is a legal procedure in                 
France​96–98 and simply a recommendation in the UK​99​. For comatose patients after cardiac arrest,              
some factors indicating very poor outcome are also now identified​100​. But for all other patients, their                
precision remains low (with a C-statistic value of 0.82 at best)​101​. 
In such cases, having a robust predictor of fatal outcome would be very helpful. It would help                 
shorten the length of stay in the ICU, avoid pointless suffering for the patient and allow more time                  
for next-of-kin support​102,103​. It would also make it possible to ​better allocate resources between              
therapeutic care for patients who are more likely to survive and palliative care for those with a very                  
reliable predictor of impending death​. But to be implemented within the routine of care, such a                
predictor will have to rely on large cohorts as well as on a robust pathophysiology. It means that                  
increasing the number of cases in the database will not be enough, due to the high-variability of                 
human bodies and conditions. In the modern world of machine learning and “artificial intelligence”,              
such a score will have to remain relatively low on the vertical line of “The Axes of Machine Learning                   
and Big Data” yet remain consistently as high as possible on the horizontal line​104​. Numerous               
initiatives are now expanding on these issues​98,100,105​. 
 
Patient fit and well-being diagnosed. ​Thanks to recent advances, a previously healthy person             
diagnosed with a fatal disease may be given a reasonable idea of their remaining life expectancy.                
From a medical perspective, even in the absence of a known cure, an optimistic approach may                
consist in trying everything to increase the life expectancy of the patient, including active therapy               
but also avoidance of treatment inasmuch as it may exacerbate the underlying condition. From a               
research perspective, studying the way of life of the patient and other comorbidities will help               
practitioners understand why a certain pathology may worsen and how to prevent it. 
From a pragmatic point of view, knowing that a patient is due to die (i.e. in the coming months) will                    
raise ethical problems regarding which treatments to offer this patient. For example, a patient              
diagnosed with a fatal disease and who suffers acute kidney injury or metastatic disease may not                
necessarily benefit from long-term dialysis or chemotherapy. Within the medical community this            
type of discussion is already commonplace, if not a daily occurrence, for a broad range of patients,                 
yet it is sometimes addressed with imprecise tools. Indeed, medical progress has made many              
pathologies survivable and there is nothing unusual today in treating an 80-year-old patient for his               
second or third cancer. Adding an objective tool will help medical teams devise the best plan of care                  
in accordance with the patient’s wishes. 
But again, it is important to emphasise here that the prediction of life expectancy may remain                
indicative for a long time, to be taken into account among several others rather than as a binary                  
answer. 
Implications for society: the case of longevity risk 
The development of predictors for impending natural death would also change the way longevity              
risk is perceived, both from a social and an individual point of view. The availability of accurate death                  
predictors could dramatically change how the risk of outliving one’s savings is perceived by              
individuals. As a consequence, the design of state pensions and long-term care systems could be               
modified. 
Managing social and economic challenges produced by the unpredictable nature and sustained            
improvement in human lifespan is an age-old issue. As discussed in the introduction, the first               
age-specific mortality model​4​, motivated by the pricing of life annuities​106​, was published in 1825.              
Since then, there has been a spectacular development of mortality models (see e.g. ​107–110​), used for                
evaluating pensions and public health reforms or regulatory reserve for pension funds and insurance              
companies​111​ . 
This so-called Longevity risk is usually subdivided into several components, including a systematic             
mortality risk - arising from unknown future improvement in mortality reduction; and an             
idiosyncratic risk - correlated to the unpredictability of an individual’s date of death.  
First, ​personalized measurement of physiological age would substantially reduce the systematic risk​.            
Such measures would open a whole new field of research for developing more accurate mortality               
models, which could be based on observable frailty indicators, and thus a better assessment of the                
longevity risk for society. 
Pension and long-term care providers (states, pension funds, insurance companies…) cannot           
evaluate how long benefits will need to be paid to an individual and are therefore faced with                 
significant idiosyncratic risk in addition to the systemic risk. Having access to accurate individual              
death predictors could reduce this idiosyncratic risk by reducing the residual variance of late-life              
phase individuals. This would be particularly relevant for small providers, heterogeneous groups or             
individualised retirement systems in which individuals bear their own longevity risk. 
 
But the implementation of death predictors is also likely to challenge solidarity and risk-pooling              
principles on which many retirement and long term-care systems are built, thereby encouraging             
more individualised organisations. Indeed, the unpredictable nature of one’s date of death is a              
strong incentive for one’s willingness to contribute to the pool and risk-sharing systems, which entail               
both the prospect of obtaining less than contributed (for instance in retirement benefits) and the               
counterbalancing insurance against one’s own longevity risk (risk of outliving one’s savings).            
However, if better death predictors were to become available, s​hould individuals with a shorter              
remaining lifespan be authorized to withdraw from retirement systems that share the longevity risk? 
This looming issue is reminiscent of the current questions surrounding solidarity ​between groups             
known to have different life expectancies​. For instance, it is already the case that insurance               
companies are not allowed to charge higher premiums to women​112​, including for longevity related              
products, even though women are known to live longer than men. Some concerns have also been                
raised regarding “unfair” redistribution properties of public pension systems in the presence of             
socioeconomic differences in mortality (see e.g. ​113–116​). Indeed, these systems could produce “an             
undesirable transfer of wealth away from lower socioeconomic groups with shorter life expectancy             
to higher socioeconomic groups with above average longevity”​114​. The magnitude of such challenges             
would be vastly expanded in the presence of individualised death predictors. The solidarity principles              
of pensions and long-term care systems could be jeopardised, or at least redefined. 
The most urgent question to answer might be: which institutions, if any, should have access to                
information on death predictors? For instance, should an individual have to disclose the information              
that they have entered the “countdown’’ phase of their life? Again, this issue echoes present ones,                
since policyholders already have to disclose to insurance companies pieces of information (smoking             
habits, previous illnesses…) known to be determinants of mortality​117​. Thus, the availability of             
massive amounts of individual data relevant for death prediction might be one of the most               
important regulatory challenges of the coming decades.  
Conclusions 
The biological research on ageing presented in the first part invites us to consider death               
prediction and to identify and analyse its ethical, medical and social implications, both from an               
individual and a collective standpoint. Such research leads to consider the prediction of death as an                
object requiring multidisciplinary reflection. Without claiming to be exhaustive, in this article we             
have applied this very method, focusing specifically on biology, philosophy, psychology, medicine,            
demography and actuarial sciences.  
From a conceptual and ethical standpoint, philosophical and psychological approaches are           
enriched by an analysis that distinguishes aspects of the relationship to death that are often               
considered as an interwoven whole: the awareness of one's own mortality, the challenge of              
anticipating one's death, and finally the issues that arise from predicting it.  
The reflections presented here are intended to outline the issues to be addressed, both              
individually and collectively. What kind of medicine and health-care do we want? What collective              
organisation do we want to adopt, in terms of insurance? What are we, as human beings, able to                  
apprehend and what would we prefer to ignore? What information about ourselves do we allow to                
circulate and do we accept to share?  
The present work provides a framework for identifying and examining forthcoming issues, such as              
conditions and consequences of a (potential) clinical use of death prediction, risks associated with              
private interests taking control of information obtained in that context, and potential increased             
 
psychological vulnerability. These issues can therefore be addressed head on rather than be viewed              
as unspecified “risks” that may eventually need to be tackled in future. According to the authors of                 
this study, the issues associated with death prediction should be addressed upstream. A             
multidisciplinary and foresight-based approach must go hand in hand with biological research on             
death prediction. 
In conclusion, the development of new, powerful tools for assessing individuals’ short to midterm              
life expectancy will bring new challenges but also - and it is important to keep this in mind - great                    
opportunities; it will open new ways of looking after ageing patients, their diseases as well as the                 
care offered to them and, as such, allow a transition from a mostly curative approach to better                 
consideration for palliative solutions, which may contribute to a better acceptance of death in our               
ageing societies.  
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